Literature DB >> 14370378

Kemadrin in the treatment of parkinsonism.

R S SCHWAB, M E CHAFETZ.   

Abstract

Entities:  

Keywords:  MUSCLE RELAXANTS/therapeutic use; PARALYSIS AGITANS/therapy

Mesh:

Substances:

Year:  1955        PMID: 14370378     DOI: 10.1212/wnl.5.4.273

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

2.  In vitro metabolism of procyclidine in the rat.

Authors:  G Paeme; R Grimee; A Vercruysse
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Oct-Dec       Impact factor: 2.441

3.  Phenobarbital induction of procyclidine metabolism: in vitro study.

Authors:  G Paeme; H Van Bossuyt; A Vercruysse
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.